共 97 条
[1]
McGinley MP(2021)Diagnosis and treatment of multiple sclerosis: a review JAMA 325 765-79
[2]
Goldschmidt CH(2012)The selective sphingosine 1-phosphate receptor modulator BAF312 redirects lymphocyte distribution and has species-specific effects on heart rate Br J Pharmacol 167 1035-47
[3]
Rae-Grant AD(2013)Siponimod for patients with relapsing-remitting multiple sclerosis (BOLD): an adaptive, dose-ranging, randomised, phase 2 study Lancet Neurol 12 756-67
[4]
Gergely P(2016)Safety and efficacy of siponimod (BAF312) in patients with relapsing-remitting multiple sclerosis: Dose-blinded, randomized extension of the phase 2 BOLD study JAMA Neurol 73 1089-98
[5]
Nuesslein-Hildesheim B(2018)Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study Lancet 391 1263-73
[6]
Guerini D(2018)Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria Lancet Neurol 17 162-73
[7]
Brinkmann V(2021)Siponimod associated macular edema in a patient with multiple sclerosis Neuroimmunol Rep 1 100031-71
[8]
Traebert M(2022)Siponimod-related bilateral cystoid macular oedema and intravenous fluorescein angiographic findings in a patient with stable proliferative diabetic retinopathy without history of diabetic macular oedema BMJ Case Rep 15 11-802
[9]
Bruns C(2020)Drug-induced maculopathy Curr Opin Ophthalmol 31 563-1002
[10]
Selmaj K(2013)Drug-induced macular edema Drugs 73 789-94